Petmed Express Inc income statement
In fiscal 2026, Petmed Express Inc reported revenue of $179m, down 21.1% on the year before, operating income of −$58.7m (a -32.8% margin) and net income of −$57.3m, or −$2.74 per diluted share. Every line below comes from the company's 10-K and 10-Q filings; column headings link to the filing.
Income statement
| Fiscal year | 2010Mar 2010 | 2011Mar 2011 | 2012Mar 2012 | 2013Mar 2013 | 2014Mar 2014 | 2015Mar 2015 | 2016Mar 2016 | 2017Mar 2017 | 2018Mar 2018 | 2019Mar 2019 | 2020Mar 2020 | 2021Mar 2021 | 2022Mar 2022 | 2023Mar 2023 | 2024Mar 2024 | 2025Mar 2025 | 2026Mar 2026 | LTMJun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 238 | 232 | 238 | 228 | 233 | 229 | 235 | 249 | 274 | 283 | 284 | 304 | 272 | 248 | 274 | 227 | 179 | 169 |
| Cost of revenue | — | — | — | — | — | — | 158 | 170 | 176 | 188 | 203 | 219 | 195 | 171 | 189 | 158 | — | — |
| Gross profit | 92 | 84 | 80 | 77 | 78 | 76 | 76 | 79 | 98 | 95 | 81 | 84 | 77 | 77 | 85 | 69 | 50 | 47 |
| General and administrative | 22 | 22 | 22 | 22 | 21 | 21 | 21 | 23 | 24 | 25 | 25 | 30 | 31 | 42 | 55 | 39 | 51 | 49 |
| Operating income | 41 | 33 | 26 | 27 | 28 | 28 | 32 | 37 | 52 | 46 | 31 | 31 | 24 | 6 | −8 | −2 | −59 | −31 |
| Income before tax | 41 | 33 | 26 | 27 | 28 | 28 | 33 | 38 | 54 | 49 | 34 | 31 | 24 | 7 | −6 | −1 | −57 | −29 |
| Income tax | 15 | 12 | 10 | 10 | 10 | 10 | 12 | 14 | 17 | 11 | 8 | 7 | 5 | 2 | 1 | 6 | −0 | −0 |
| Net income | 26 | 21 | 17 | 17 | 18 | 17 | 21 | 24 | 37 | 38 | 26 | 24 | 19 | 5 | −7 | −6 | −57 | −29 |
| Diluted EPS | $1.14 | $0.92 | $0.80 | $0.86 | $0.90 | $0.87 | $1.02 | $1.17 | $1.82 | $1.84 | $1.29 | $1.19 | $0.92 | $0.25 | −$0.37 | −$0.30 | −$2.74 | −$1.38 |
| Diluted shares (average) | 23m | 23m | 21m | 20m | 20m | 20m | 20m | 20m | 20m | 20m | 20m | 20m | 20m | 20m | 20m | 21m | 21m | 21m |
| EBITDA | — | — | 27 | 28 | 29 | 28 | 33 | 39 | 54 | 48 | 33 | 33 | 27 | 10 | −1 | 6 | −49 | −22 |
| Quarter | 2025 Q2Sept 2024 | 2025 Q3Dec 2024 | 2025 Q4Mar 2025 | 2026 Q1Jun 2025 | 2026 Q2Sept 2025 | 2026 Q3Dec 2025 | 2026 Q4Mar 2026 | 2027 Q1Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 58 | 52 | 51 | 51 | 44 | 41 | 43 | 41 |
| Cost of revenue | 39 | 36 | 36 | 37 | 32 | — | — | 30 |
| Gross profit | 19 | 16 | 15 | 14 | 12 | 9 | 14 | 11 |
| General and administrative | 10 | 11 | 12 | 13 | 14 | 12 | 11 | 11 |
| Operating income | 1 | −0 | −6 | −34 | −8 | −10 | −6 | −6 |
| Interest expense | — | 0 | — | 1 | — | 0 | — | 0 |
| Income before tax | 1 | −0 | −6 | −34 | −9 | −11 | −4 | −6 |
| Income tax | −1 | 0 | 6 | 0 | 0 | 0 | −0 | 0 |
| Net income | 2 | −1 | −12 | −34 | −9 | −11 | −4 | −6 |
| Diluted EPS | $0.11 | −$0.03 | −$0.56 | −$1.65 | −$0.41 | −$0.50 | −$0.19 | −$0.28 |
| EBITDA | 2 | 1 | −4 | −32 | −6 | −8 | −3 | −4 |
Compare with peers
- SBC Medical Group Holdings Inc income statement
- Airsculpt Technologies, Inc. income statement
- NRC Health income statement
- Ridgetech Inc. income statement
- DLH Holdings Corp. income statement
Head to head: PETS vs SBCAIRS vs PETSNRC vs PETSPETS vs RDGT
More: Health Care Services stocks compared, Health Care sector, rankings of US companies